Skip to content
DataLookout
Menu

MICRO-LTBINCT06728930

Evaluation of a Novel Microbiological Diagnostic Test for Latent Mycobacterium Tuberculosis Infection

StatusEnrolling by Invitation
PhaseNot specified
Primary completion (estimated)

At risk: Primary completion moved at least 11 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 2 with changes below, 2 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Oct 2026 to Oct 2027
    • Eligibility criteria expanded, about 15 words
    • Study description expanded, about 15 words
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Prevalence of Mtb DNA in blood
Timeframe: 3 years

Arms and interventions

Latent TB screenees

Patients attending TB clinic who are being screened for latent TB. Includes recent migrants from a country with high TB prevalence, occupational health referrals with a positive IGRA, household contacts of TB cases and patients who are about to start biological therapy (eg. anti-TNF)

Active TB patients

Patients with active TB who are not already on anti-tuberculous treatment

Sites

1 site in 1 country

  • Blizard Institute, Queen Mary University LondonLondon, United Kingdom